Related references
Note: Only part of the references are listed.Warfarin and food, herbal or dietary supplement interactions: A systematic review
Christina San San Tan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Optimal oral anticoagulant therapy in Chinese patients with mechanical heart valves
Heng Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Rivaroxaban in patients with mechanical heart valves: A pilot study
Eva Roost et al.
THROMBOSIS RESEARCH (2020)
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations
Minami Ohara et al.
CLINICAL PHARMACOKINETICS (2019)
ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management JACC Guideline Comparison
Maninder Singh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk
Alex C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Human serum albumin in cardiovascular diseases
Stephane Arques
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study
Daniela Poli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Clotting-Factor Concentrations 5 Days After Discontinuation of Warfarin
Honorio T. Benzon et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
Raffaele De Caterina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Anticoagulant action of low, physiologic, and high albumin levels in whole blood
Margret Paar et al.
PLOS ONE (2017)
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Rick A. Nishimura et al.
CIRCULATION (2017)
Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy
Paula Mendonca Leite et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Rick A. Nishimura et al.
CIRCULATION (2014)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Perioperative Management of Antithrombotic Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
James D. Douketis et al.
CHEST (2012)
International normalized ratios (INR): the first 20 years
L Poller
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh et al.
CHEST (2001)
Share Paper
